Healthcare Services Buyers & Acquisitions in Massachusetts

Tracked deals

183

183 tracked deals across 2015-2026.

Buyer mix

Mixed buyer set

149 strategic · 104 pe

Top trend

Volume peaked in 2022

33 tracked deals announced in 2022.

Primary Insight

What Stands Out

  • Azara Healthcare acquired Advocatia to support Medicaid redetermination coverage workflows for safety-net providers and health plans.
  • Coastal Medical Transportation Systems (CMTS) acquired Alert Ambulance Service to strengthen emergency and non-emergency transportation capacity in New England.
  • Specialty diagnostics and medical writing capabilities show up via CareDx (acquiring Naveris) and Veristat (acquiring Certara’s Regulatory and Medical Writing business).
  • Large-scale pharma deal activity is also present, including Biogen’s acquisition of Apellis Pharmaceuticals.
Recurring buyer type (examples) Where they show up What they’re adding
Service and platform operators Enrollment, transportation, wellness Service delivery workflows and capacity
Diagnostics / research enablement Oncology MRD surveillance; regulatory writing Testing platforms and development support
Large pharma Immunology/rare disease expansion Commercial products and pipeline fit

Build a buyer list for your Healthcare Services deal

Find buyers actively acquiring healthcare services companies.

Find buyers like these for your deal

Buyer Snapshot

Top Buyers

Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.

Build a buyer list for your Healthcare Services deal →
Buyer # Deals Focus Type
InTandem Capital Partners 3 Healthcare-services-focused private equity firm investing... PE
Arsenal Capital Partners 2 Private equity firm specializing in middle-market industr... PE
Ascend Learning 2 Healthcare and learning technology company offering testi... Strategic
Coastal Medical Transportation Systems (CMTS) 2 Privately owned non-emergency medical transportation prov... Strategic
GHO Capital Partners LLP 2 European specialist investor focused on healthcare growth... PE
Health Enterprise Partners 2 Healthcare-focused private equity firm providing expansio... PE
InTandem Capital Partners, LLC 2 Healthcare-services-focused private equity firm that inve... PE
Insight Partners 2 Global software investor that provides growth capital and... PE
Labcorp 2 Leading global life sciences company providing diagnostic... Strategic
Laser MD Medspa 2 Operator of a multi-location medical spa chain offering l... Strategic (PE-backed)

Acquisition Volume in Healthcare Services in Massachusetts by Year

Last 9 years

Acquisition volume by year Annual acquisition counts for the last 9 years for Healthcare Services Buyers & Acquisitions in Massachusetts. 2 2018 9 2019 19 2020 31 2021 33 2022 25 2023 19 2024 24 2025 ~33 est. 17 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    Azara Healthcare
    Target
    Advocatia
    Type
    Buyout

    Azara Healthcare acquired Advocatia, a digital-first public benefits enrollment platform, to help safety-net providers and health plans maintain Medicaid coverage during redetermination. The combined solution pairs Azara’s population health and risk stratification (DRVS) with Advocatia’s guided enrollment workflow for applications, documentation, and initial enrollment/renewal in 75 languages. Terms were not disclosed, and the platform was described as available immediately to Azara clients.

  • Buyer
    Coastal Medical Transportation Systems (CMTS)
    Target
    Alert Ambulance Service
    Type
    Buyout

    Coastal Medical Transportation Systems (CMTS) acquired Alert Ambulance Service as part of its continued regional expansion across New England. The deal is intended to strengthen both emergency and non-emergency medical transportation capacity and reduce care delivery gaps by integrating Alert’s routes and workforce into CMTS’s existing network.

  • Buyer
    Collegium Pharmaceutical, Inc.
    Target
    AZSTARYS
    Seller
    Corium Therapeutics
    Type
    Buyout

    Collegium Pharmaceutical, Inc. completed its acquisition of AZSTARYS, a prescription CNS stimulant for ADHD, from Corium Therapeutics. The deal is valued at approximately $650 million in cash, with additional milestone-based consideration of up to $135 million.

  • Buyer
    Cloudstate
    Target
    Girlhood
    Type
    Buyout

    Cloudstate, a health and wellness platform for girls and young women, announced its acquisition of Girlhood, a community-driven Gen Z connection platform. The deal combines Cloudstate’s physical and emotional health expertise with Girlhood’s peer community and content ecosystem to create an “emotional safety and belonging” focused platform.

  • Buyer
    Baystate Health, Trinity Health Of New England
    Target
    Mercy Medical Center, Brightside for Families and Children, Mercy LIFE, Mary's Meadow At Providence Place, Beaven Kelly Home, Saint Luke's Home, Mercy Rehabilitation Hospital, Sister Caritas Cancer Center
    Type
    Buyout

    Baystate Health and Trinity Health of New England have signed a definitive agreement to transition Mercy Medical Center (and certain related Massachusetts JV affiliates and medical group entities) to Baystate Health, subject to regulatory approvals. The move is intended to strengthen local access to care in Western Massachusetts and improve the long-term sustainability of Mercy’s services.

  • Buyer
    CareDx, Inc.
    Target
    Naveris
    Type
    Buyout

    CareDx, Inc. entered into a definitive agreement to acquire Naveris, a commercial-stage precision oncology diagnostics company, for $160 million in upfront cash plus up to $100 million in revenue-based milestones. The transaction is expected to close in the third quarter of 2026 and expands CareDx’s precision medicine testing services into HPV-driven cancer MRD surveillance using Naveris’ TTMV DNA (NavDx) liquid biopsy platform.

  • Buyer
    Veristat, WindRose Health Investors, LLC
    Target
    Certara's Regulatory and Medical Writing business
    Seller
    Certara, Inc.
    Type
    Buyout

    Veristat announced it has entered into a definitive agreement to acquire Certara’s Regulatory and Medical Writing business. The deal is expected to close in Q2 2026 and will add 200+ (approximately 220) medical writing and regulatory experts to expand Veristat’s regulatory writing, submission strategy, and advisory capabilities across the drug development lifecycle.

  • Buyer
    Obsidian Therapeutics, Inc., Galera Therapeutics, Inc., Newly formed company (to be operated as Obsidian Therapeutics, Inc.)
    Target
    Obsidian Therapeutics, Inc., Galera Therapeutics, Inc.
    Type
    Buyout

    Obsidian Therapeutics and Galera Therapeutics entered into a definitive all-stock merger agreement in which both companies will become wholly owned subsidiaries of a newly formed company. The combined company is expected to operate as Obsidian Therapeutics, Inc. and apply to list on Nasdaq under ticker OBX, supported by a $350 million concurrent private placement.

  • Buyer
    Flow Capital Corp.
    Target
    MiniLuxe Holding Corp.

    Flow Capital Corp. announced a US$1.75 million follow-on investment commitment in MiniLuxe Holding Corp., including a first tranche advance of US$1.35 million. The additional capital—if fully drawn—would bring Flow Capital’s total aggregate investment in MiniLuxe to US$7.925 million across four deployments, supporting studio growth and expansion via franchising, joint ventures, and acquisitions.

  • Buyer
    Biogen Inc.
    Target
    Apellis Pharmaceuticals, Inc.
    Type
    Buyout

    Biogen entered into a definitive agreement to acquire Apellis Pharmaceuticals in a ~$5.6 billion cash deal ($41 per share) that also includes contingent value rights (CVRs) tied to SYFOVRE sales performance. The transaction closed in May 2026 and made Apellis a wholly owned subsidiary of Biogen, adding commercial products EMPAVELI and SYFOVRE to Biogen’s immunology/rare disease portfolio and strengthening its expansion into nephrology.

  • Buyer
    Cambridge Innovation Institute (CII)
    Target
    Neurotech Reports
    Type
    Buyout

    Cambridge Innovation Institute (CII) announced it has acquired Neurotech Reports, a neurotechnology publication and conference series. CII said the deal expands its healthcare portfolio within its Cambridge VIP division, with the first joint event being the Bioelectronic Medicine Forum on April 14 in New York City.

  • Buyer
    Waters Corporation
    Target
    BD Biosciences & Diagnostic Solutions business
    Seller
    Becton, Dickinson and Company (BD)
    Type
    Buyout

    Waters Corporation completed its previously announced combination of BD’s Biosciences and Diagnostic Solutions business with a wholly owned Waters subsidiary, creating a global life sciences and diagnostics leader focused on high-volume testing in regulated applications. BD spun off the business and received Waters equity, with BD receiving $4 billion in cash in connection with the transaction.

  • Buyer
    Konovo
    Target
    Rare Patient Voice (RPV)
    Seller
    Wes Michael (Founder and President of Rare Patient Voice)
    Type
    Buyout

    Konovo, a technology-first healthcare intelligence company, announced it has acquired Rare Patient Voice (RPV), a patient recruitment company with 200,000+ registered patients and family caregivers. The acquisition combines RPV’s patient community and recruitment expertise with Konovo’s intelligent platform and global HCP access to help researchers engage both patients and healthcare providers with speed and reliability.

  • Buyer
    Harmony Healthcare IT
    Target
    Blue Elm
    Type
    Addon

    Harmony Healthcare IT, a Novacap portfolio company based in South Bend, Indiana, has acquired Blue Elm, a MEDITECH data solutions provider headquartered in Natick, Massachusetts. The add-on expands Harmony's MEDITECH EHR data extraction, migration, optimization and archiving capabilities, consolidating a single partner for hospitals' MEDITECH data lifecycle.

  • Buyer
    BGB Group
    Target
    Hayden Consulting Group
    Type
    Addon

    BGB Group has acquired Hayden Consulting Group to expand its market access and patient services capabilities within its Strategic Advisory practice. Hayden will continue to be led by co-founders Jamie Sidore and David MacDougall, and financial terms were not disclosed.

  • Buyer
    Element Solutions Inc
    Target
    EFC Gases & Advanced Materials
    Type
    Buyout

    Element Solutions Inc. has completed its previously announced acquisition of EFC Gases & Advanced Materials (EFC) for approximately 12x forecasted 2026 adjusted EBITDA in cash. EFC will operate as a standalone business unit within Element Solutions’ newly renamed “Specialties Segment,” expanding capabilities in specialty and rare gases, advanced materials, and semiconductor- and space-related growth vectors.

  • Buyer
    SHINE Technologies
    Target
    Lantheus SPECT business, Lantheus' SPECT division, North Billerica, Massachusetts SPECT manufacturing facility
    Seller
    Lantheus
    Type
    Buyout

    SHINE Technologies completed its acquisition of Lantheus’ SPECT business, including the North Billerica, Massachusetts manufacturing facility and the diagnostic radiopharmaceutical product portfolio. The deal expands SHINE’s nuclear medicine platform with established SPECT production expertise and market relationships, positioning SHINE to strengthen the medical isotope supply chain for diagnostic imaging.

  • Buyer
    Charlesbank Technology Opportunities Fund II (Charlesbank Capital Partners)
    Target
    HBox

    HBox, a virtual care platform for specialty practices, received a growth investment from Charlesbank’s Technology Opportunities Fund II to accelerate expansion of its virtual care capabilities and scale its remote monitoring and patient-engagement offerings. The transaction closed on December 17, 2025 and will support HBox’s efforts to broaden specialty coverage (cardiology, pulmonology, nephrology) and strengthen its position as a virtual clinic partner for independent specialty practices.

  • Buyer
    InTandem Capital Partners, HarbourVest Partners, Partners Capital, WestView Capital Partners
    Target
    The Phia Group

    InTandem Capital Partners completed an equity investment in The Phia Group, a Canton, Massachusetts-based leader in healthcare cost containment. HarbourVest Partners and Partners Capital joined as co-investors, while WestView Capital Partners remains a significant existing investor; advisors to the transaction included Houlihan Lokey and TripleTree.

  • Buyer
    Innovative Lab Services LLC
    Target
    Overbrook Scientific
    Type
    Buyout

    Innovative Lab Services (ILS) has acquired Overbrook Scientific, a provider of laboratory relocations, asset management, and multi-vendor instrument maintenance, to expand ILS's national footprint and specialized lifecycle capabilities. Overbrook's founder Ted Palashis and the full Overbrook team will join ILS and continue to lead laboratory lifecycle and technical services within the combined organization.

  • Buyer
    Activated Insights
    Target
    CareAcademy
    Type
    Addon

    Activated Insights, a Cressey & Company–backed workforce enablement platform, has acquired CareAcademy to create an expanded workforce development and compliance training offering for long-term and post-acute care providers. The combined organization will integrate CareAcademy's training and compliance automation with Activated Insights' analytics, benchmarking, recruiting tools and interoperability to deliver a unified platform for home care, home health, hospice, assisted living and skilled nursing providers.

  • Buyer
    Cogir Real Estate
    Target
    Epoch Senior Living management platform
    Seller
    Epoch Senior Living
    Type
    Buyout

    Cogir Real Estate has acquired the management platform of Epoch Senior Living, adding 16 senior living communities across Massachusetts, Connecticut, New York and New Hampshire. The Epoch team will remain in place, bringing over 1,300 employees and creating a new U.S. platform for Cogir to expand its presence in the Northeastern United States.

  • Buyer
    MD Esthetics, New Harbor Capital
    Target
    Joli Medical Spa
    Seller
    Kristen MacNeil (Founder of Joli Medical Spa)
    Type
    Addon

    MD Esthetics, a New Harbor Capital portfolio company, has completed the acquisition of Joli Medical Spa, a Marshfield, Massachusetts-based medical spa founded by Kristen MacNeil. The transaction is an add-on that expands MD Esthetics' geographic footprint across the Boston and Cape Cod markets and brings Joli's seven licensed injectors and aestheticians onto the MD Esthetics platform.

  • Buyer
    Arlington Capital Partners
    Target
    Concord Biomedical Sciences and Emerging Technologies, Inc. (CBSET)

    Arlington Capital Partners completed a majority growth investment in Concord Biomedical Sciences and Emerging Technologies, Inc. (CBSET), a Boston-area provider of translational research and product development services for the medical device and life sciences markets. The investment is intended to help CBSET scale its integrated preclinical research and testing platform via capacity expansion and strategic add-on acquisitions.

  • Buyer
    Keensight Capital
    Target
    Isto Biologics
    Seller
    Thompson Street Capital Partners (TSCP)
    Type
    Buyout

    Keensight Capital has agreed to acquire a majority stake in regenerative MedTech company Isto Biologics. Thompson Street Capital Partners (TSCP) will retain a minority stake alongside Isto’s management team.

  • Buyer
    Ascend Learning
    Target
    Laudio
    Type
    Buyout

    Ascend Learning has acquired Laudio, an AI-enhanced frontline leader operations platform, to expand its healthcare workforce management and leadership capabilities. The acquisition integrates Laudio’s leader operations tools into Ascend’s learning and workforce solutions to better support frontline managers and improve employee engagement and patient experience.

  • September 3, 2025
    Buyer
    PurpleLab
    Target
    KAID Health
    Type
    Buyout

    PurpleLab has acquired KAID Health to combine PurpleLab’s large-scale structured claims data with KAID Health’s AI and natural language processing capabilities, creating an integrated view of patient journeys across structured and unstructured data. The acquisition is intended to expand PurpleLab’s AI-powered healthcare intelligence offerings and accelerate capabilities for coding accuracy, care management, clinical research, and value-based care initiatives.

  • Buyer
    SCH Capital Holdings, Inc.
    Target
    Statera
    Type
    Addon

    SCH Capital Holdings, Inc. has acquired Boston-based Statera, a healthcare compensation management technology and consulting firm. Statera will be integrated into SCH's Clinician Nexus platform to expand physician compensation automation and analytics capabilities across health systems, academic medical centers, and clinician groups.

  • Buyer
    VaLogic Bio
    Target
    Air Systems Technologies (AST)
    Type
    Buyout

    VaLogic Bio has acquired Air Systems Technologies (AST), a cleanroom certification and biosafety-testing specialist headquartered in Avon, Massachusetts. The acquisition expands VaLogic's service offerings for life sciences customers and strengthens its presence across the Mid-Atlantic and New England; AST will continue operating in Avon as VaLogic Bio.

  • Buyer
    Pyx Health, S2G Investments, TT Capital Partners
    Target
    FarmboxRx
    Seller
    Farmbox Direct, Inc.
    Type
    Buyout

    Pyx Health has acquired FarmboxRx after receiving a $47.5 million investment from S2G Investments in strategic partnership with TT Capital Partners. The deal integrates FarmboxRx's customized food-box solutions into Pyx Health's mentor-driven care navigation platform to address food insecurity and strengthen member engagement for health plans, particularly in Medicare and Medicaid populations.

  • Buyer
    BioMarin Pharmaceutical Inc.
    Target
    Inozyme Pharma, Inc.
    Type
    Buyout

    BioMarin Pharmaceutical Inc. completed its all-cash acquisition of Inozyme Pharma, Inc. for $4.00 per share, valuing the deal at approximately $270 million. The transaction adds INZ-701, a late-stage enzyme replacement therapy being developed for ENPP1 Deficiency, to BioMarin’s enzyme therapies portfolio.

  • Buyer
    Carlyle, SK Capital Partners, LP, Beacon Parent Holdings, L.P., Beacon Merger Sub, Inc.
    Target
    bluebird bio, Inc.
    Type
    Buyout

    bluebird bio entered into a definitive agreement to be acquired by funds managed by Carlyle and SK Capital Partners, with expected close in the first half of 2025. Under the deal, bluebird stockholders are set to receive $3.00 per share in cash plus a contingent value right (CVR) of up to $6.84 per share if a net sales milestone is achieved by 2027 (or an alternative $5.00 per share cash option later added).

  • Buyer
    Packaging Compliance Labs, SV Health Investors
    Target
    Quest Engineering Solutions
    Type
    Addon

    Packaging Compliance Labs (PCL), a PE-backed provider of sterile packaging and testing services, has acquired Quest Engineering Solutions, an ISO 17025-accredited test lab based in Billerica, Massachusetts. The add-on expands PCL's East Coast footprint and broadens its testing capabilities for medical device and life sciences customers; PCL is backed by SV Health Investors.

  • Buyer
    GHR Healthcare
    Target
    Barton Healthcare Staffing
    Seller
    Barton Associates, Inc.

    GHR Healthcare has acquired Barton Healthcare Staffing, the nurse and allied health staffing affiliate of Barton Associates, Inc., with the transaction closing on May 3, 2025. The deal transfers Barton Healthcare Staffing’s nurse and allied clients and clinicians to GHR as Barton Associates refocuses on physician and advanced-practice locum tenens staffing.

  • Buyer
    Bristol Myers Squibb (BMS)
    Target
    2seventy bio, Inc.
    Type
    Buyout

    2seventy bio entered into a definitive merger agreement to be acquired by Bristol Myers Squibb (BMS) for $5.00 per share in an all-cash transaction. The deal is expected to close in the second quarter of 2025, following a tender offer and a second-step merger.

  • Buyer
    Smile Doctors
    Target
    myOrthos
    Type
    Addon

    Smile Doctors has acquired myOrthos, an orthodontic support organization with over 70 affiliated locations across 13 states, expanding Smile Doctors' network to more than 550 affiliated locations in 36 states and entering four new states. The acquisition is an add-on to Smile Doctors’ platform to increase provider density in key markets while ensuring continuity of care for myOrthos’ affiliated practices and patients.

  • Buyer
    Advanced Instruments, Patricia Industries
    Target
    Nova Biomedical
    Seller
    Nova Biomedical founding shareholders (Frank Manganaro and Dr. Chung-Chang Young)
    Type
    Buyout

    Advanced Instruments, a wholly owned subsidiary of Patricia Industries, completed its acquisition of Nova Biomedical for an enterprise value of USD 2.2 billion. The transaction followed regulatory approval and resulted in the combined business operating under the Nova Biomedical name, led by Advanced Instruments’ CEO Byron Selman.

  • Buyer
    Insight Partners, Hughes & Company
    Target
    Azara Healthcare, i2i Population Health

    Azara Healthcare and i2i Population Health have joined forces to create an expanded population health and value-based care company serving safety-net providers. Global software investor Insight Partners led the merger and made a growth investment in the combined business, joining existing investor Hughes & Company; the new company will be headquartered in Burlington, Massachusetts with an office in Nashville, Tennessee.

  • Buyer
    Avel eCare
    Target
    Amwell Psychiatric Care
    Seller
    Amwell

    Avel eCare has acquired Amwell Psychiatric Care (APC) from Amwell in an all-cash transaction worth approximately $21 million at closing plus an additional earn-out. The sale transfers APC technology, personnel and the affiliated Asana psychiatric clinical network to Avel as Amwell sharpens focus on its core digital care platform and strengthens its balance sheet. The acquisition expands Avel eCare's behavioral health capabilities and broadens its national telemedicine footprint.

  • Buyer
    HouseWorks Holdings, LLC, InTandem Capital Partners
    Target
    O'Connell Care at Home, Best Home Care
    Seller
    Founders / founder-owned organizations of O'Connell Care at Home and Best Home Care
    Type
    Addon

    HouseWorks Holdings, a PE-backed home care platform, has acquired two Massachusetts-based, founder-owned home care providers: O'Connell Care at Home (Holyoke/Springfield region) and Best Home Care (Wakefield). These add-on transactions expand HouseWorks' presence across Western Massachusetts and Greater Boston and represent the company's second and third acquisitions in the state since partnering with InTandem Capital in December 2022.

  • Buyer
    Bregal Sagemount, Primus Capital
    Target
    MDaudit

    MDaudit, a Waltham, Massachusetts–based provider of billing, coding compliance and revenue integrity SaaS for healthcare providers, received a strategic growth investment from growth equity firm Bregal Sagemount, with existing investor Primus Capital also committing additional capital. Terms were not disclosed; the capital will be used to accelerate growth, new product development and expand MDaudit's market leadership in revenue cycle management.

  • Buyer
    SightMD
    Target
    Papale Eye Center
    Type
    Addon

    SightMD acquired Papale Eye Center in 2025, marking SightMD’s first expansion into Massachusetts and adding a Springfield-based ophthalmology and laser eye surgery practice to its network. The Papale Eye Center will continue offering cataract, LASIK and other vision-correction services as part of the SightMD platform, expanding SightMD’s regional footprint and access to surgical capabilities.

  • Buyer
    Tarrytown Expocare Pharmacy, Sheridan Capital Partners
    Target
    Greater Boston Long Term Care Pharmacy
    Seller
    Mike Wessenberg (Founder / Former CEO)
    Type
    Addon

    Tarrytown Expocare Pharmacy, a national long-term care pharmacy focused on IDD and behavioral health, has acquired Greater Boston Long Term Care Pharmacy to establish a Massachusetts presence. The deal, supported by Sheridan Capital Partners and advised on the sell-side by M&A Healthcare Advisors, adds a regional location to Tarrytown's platform and aims to expand services to group homes and assisted living communities across the Commonwealth.

  • Buyer
    Mubadala Investment Company, Norwest, HarbourVest
    Target
    Zelis

    Zelis, a Boston-based healthcare technology company, sold a minority stake to a group of investors led by Mubadala Investment Company and including Norwest and HarbourVest, with Parthenon and Bain Capital remaining the majority owners. The transaction closed November 26, 2024 and brings strategic capital and investor support to fuel Zelis's continued growth in healthcare payments and financial technology.

  • Buyer
    IEH Laboratories & Consulting Group
    Target
    Founders Science Group
    Seller
    Founders of Founders Science Group (including Robert Munroe)
    Type
    Buyout

    IEH Laboratories & Consulting Group has acquired Founders Science Group (FSG), an analytical testing and formulation services lab based in Taunton, Massachusetts. The deal enabled one founder to retire while preserving the business operations and expands IEH's pharmaceutical and beauty-product testing capabilities within its global lab network.

  • Buyer
    NationsBenefits
    Target
    Good Measures
    Seller
    Spencer Trask & Co.
    Type
    Buyout

    NationsBenefits has acquired Good Measures, a Food-as-Medicine platform that combines clinical coaching, patented nutrition technology, and personalized food prescriptions. The acquisition integrates Good Measures' capabilities into NationsBenefits' supplemental benefits and fintech platform to expand medically-tailored nutrition offerings for health plans and their members across the United States.

  • Buyer
    Rural Healthcare Group (Revere Medical), Kinderhook Industries, LLC
    Target
    Steward Medical Group, Steward Health Care Network
    Seller
    Steward Health Care
    Type
    Addon

    Rural Healthcare Group (owned by private equity firm Kinderhook Industries) has acquired Steward Medical Group and Steward Health Care Network, consolidating the primary care clinics formerly part of Steward's hospital system into RHG’s platform. RHG will rebrand as Revere Medical, invest in clinic infrastructure and operations, and aim to preserve local primary care access across Massachusetts and nine other states.

  • Buyer
    Ascend Learning
    Target
    StaffGarden
    Type
    Buyout

    Ascend Learning has acquired StaffGarden, a cloud-based clinical talent development and compliance platform trusted by over 800 hospitals, to expand its healthcare workforce development capabilities. The acquisition will integrate StaffGarden's digital clinical ladder and competency-management tools into Ascend Learning's portfolio to help health systems address retention and professional development challenges.

  • Buyer
    ProductLife Group (PLG)
    Target
    Halloran Consulting Group
    Type
    Buyout

    ProductLife Group (PLG), a global life‑sciences consulting and outsourcing firm, has acquired Halloran Consulting Group, a U.S.-based life sciences consulting firm with offices in Boston and San Diego. The acquisition expands PLG’s regulatory, quality, clinical, and organizational capabilities while strengthening its presence in the North American market to better support pharmaceutical, biotech, and medical device clients.

  • Buyer
    Lawrence General Hospital, Newly formed not-for-profit (unnamed)
    Target
    Holy Family Hospital (Methuen campus), Holy Family Hospital (Haverhill campus)
    Seller
    Steward Health Care System

    Lawrence General Hospital, together with a newly formed not-for-profit, acquired the assets and operations of Holy Family Hospital's Methuen and Haverhill campuses from Steward Health Care System. The Bankruptcy Court‑approved transaction closed on October 1, 2024 for $28 million and transferred more than 1,300 employees to the new ownership as part of creating a regional health care system in the Merrimack Valley.

Full Export

Purchase this data

Get the full acquisitions list for this page as CSV + XLSX.

Build a buyer list for your Healthcare Services deal

Find buyers actively acquiring healthcare services companies.

Apply as a Buyer

Frequently Asked Questions

What kinds of healthcare services deals are showing up in Massachusetts?

Recent Massachusetts transactions include healthcare enrollment and care coordination platforms (e.g., Azara Healthcare / Advocatia) and regional medical transportation capacity expansion (Coastal Medical Transportation Systems (CMTS) / Alert Ambulance Service).

Are these deals limited to providers, or do they include healthcare technology and diagnostics?

They include a mix. Alongside services-oriented transactions, the page also reflects diagnostics and development services activity such as CareDx acquiring Naveris and Veristat acquiring Certara’s Regulatory and Medical Writing business.

Do the listed acquisitions stay within Massachusetts?

The transactions described are located in Massachusetts, United States, with the page consistently tied to Massachusetts activity.

What buyer names appear more than once across healthcare-related acquisitions here?

The page lists recurring buyer names including The Stepping Stones Group, Five Arrows Capital Partners, Health Enterprise Partners, Emmes, Behrman Capital, Gemini Therapeutics, Inc., Access Biotechnology, and OrbiMed.

Related Acquisition Pages